In a significant move to enhance the lives of Nigerians living with diabetes, Reliance Health, the company behind Reliance HMO in Nigeria, and Platos Health have successfully completed a pilot study demonstrating the transformative impact of innovative health tech solutions on chronic disease management. This collaboration highlights the power of technology to empower individuals to take charge of their health, while achieving substantial cost savings.
The study set out to evaluate the effectiveness and economic benefits of Platos, a virtual platform for chronic disease management, for Reliance HMO enrollees. The results reveal a promising future for diabetes care in Nigeria, with notable health improvements and cost reductions.
In an interview with Pharmanewsonline, Dr Ugochi Nwosu, senior vice-president of Clinical Services, Reliance Health, outlined the major outcomes of the study to include, notable improvement in blood sugar levels within the space of over 12 weeks or about 3 months of treatment, as participants saw an average reduction of approximately 12 per cent in fasting blood sugar levels, a critical factor in managing diabetes effectively.
She further identified a significant reduction in insulin usage as another remarkable result of the research. The total insulin required to maintain blood sugar control dropped by about 15 per cent, from 94 IU to 80 IU. This reduction, she said, is particularly impressive, with two participants achieving a major 43 per cent and 20 per cent decrease in insulin use, respectively. The decreased need for insulin translates to estimated savings of over N88,000 for both the insurance provider and its enrollees during the three months under review.
“These outcomes underscore the positive impact of integrating advanced health tech solutions into chronic disease management. By leveraging the virtual platform provided by Platos Health, Reliance Health enrollees were able to achieve better health outcomes with fewer resources, enhancing their quality of life while reducing healthcare costs.
“This pilot study demonstrates the incredible potential of technology to improve patient health outcomes and reduce costs. We are proud to partner with Platos Health to bring such impactful solutions to our enrollees,” Nwosu remarked.
Platos Health’s Senior Medical Advisor, Dr Itopa Jimoh, also expressed his satisfaction with the impact of Reliance services on their clients’ health, especially in the management of chronic conditions.
“We are delighted to see the positive changes in the lives of Reliance HMO enrollees. Our mission is to make effective chronic disease management accessible to everyone, and this study reinforces the value of our platform in achieving that goal.
“This successful pilot study not only showcases the effectiveness of Platos Health’s platform but also highlights the commitment of Reliance Health to invest in innovative solutions that empower individuals and transform healthcare delivery in Nigeria. Together, these companies are paving the way for a healthier, more cost-effective future,” he assured.
Reliance Health is a leading health tech company providing innovative healthcare solutions to individuals and organizations. Through its health insurance plans, telemedicine services, and a network of healthcare providers, Reliance Health is committed to making healthcare accessible and affordable.
Platos Health is a virtual platform dedicated to chronic disease management. By leveraging technology, Platos Health aims to provide effective and personalized care for individuals managing chronic conditions, ultimately improving their quality of life.
